cript>
array

Global Blood Glucose Devices Market Report (2022 to 2027)

Global Blood Glucose Devices Market Report (2022 to 2027)
..

DUBLIN , May 13, 2022 /PRNewswire/ — The “Blood Glucose Device Market, Users Global Forecast 2022-2027, SMBG Components, Industry Trends, Growth, Insight, Impact of COVID-19, Company Analysis” report has been added to ResearchAndMarkets.com’s offering.

Research and Markets Logo

The report provides a detailed analysis of Self-Monitoring Blood Glucose Devices Industry. The global Self-Monitoring Blood Glucose Devices Market is expected to reach US$ 46.69 trillion in 2027.

Over time, typical lab diagnostic tests have only served to assist physicians in diagnosing disease. Patients with more fluctuating glucose levels, on the other hand, need their levels monitored every day. Also, patients who use insulin need to regularly monitor their blood glucose levels. As a result, a current diabetes care approach involving blood glucose meters by patients to promptly check their glucose levels and provide an accurate assessment of capillary glucose concentration is known as self-monitoring blood glucose (SMBG). Additionally, blood glucose monitoring aids diabetic patients in making daily management decisions such as food consumption, insulin dosage, and physical activity.

Self-Monitoring Blood Glucose Devices Industry is anticipated to expand with a CAGR of 4.12% from 2021 to 2027:

The increased prevalence of diabetes is attributable to the market growth of self-monitoring blood glucose gadgets. Furthermore, lifestyle changes, food choices, increased smoking, and alcohol intake are likely to increase diabetes prevalence rates. Again, as people become more aware of home monitoring and the importance of regular diabetes treatment to lower the risk of hyperglycemia, the demand for self-monitoring blood glucose monitors is increasing.

In addition, the government is launching several programs to raise public awareness about early diagnosis. The National Diabetes Education Program (NDEP) collaborated with the Centers for Disease Control and Prevention (CDC) and the NIH. The National Diabetes Education Program (NDEP) strives to lessen the prevalence of prediabetes by delivering diabetes-related education to an eclectic group of people, including hard-to-reach inhabitants, faith-based communities, ethnic minorities, community-based organizations, and healthcare providers.

COVID-19 Influence on Self-Monitoring Blood Glucose Devices Industry:

The COVID-19 epidemic has augmented the growth of the Self-Monitoring Blood Glucose Devices Market. Due to the pandemic, a few market participants reported an increase in diabetes care revenue. For example, Abbott claimed in June 2020 that their glucose monitoring device FreeStyleLibre accounted for 59.3 percent of the company’s sales growth in the first quarter of 2020. With the increased risk of coronavirus transmission among diabetes patients, a new focus has been on home usage monitoring devices to help patients regulate their blood glucose levels. According to the publisher, Self-Monitoring Blood Glucose Devices Market was US$36.64 trillion in 2021.

Global Self-Monitoring Blood Glucose Devices Market Segmentation:

The self-monitoring blood glucose devices industry is categorized into Type 1 Diabetes and Type 2 Diabetes perspective for Diabetes Population, Blood Glucose Devices (SMBG) Market (Test Strips, Lancet, Glucose Meter), Blood Glucose Device (SMBG) Users and Reimbursement of Blood Glucose Devices of 17 Countries (United States, United Kingdom, Germany, Spain, Italy, Netherlands, Norway, Sweden, Switzerland, Australia, Kuwait, Brazil, Russia, India, China, South Africaand Saudi Arabia)

Competitive Landscape:

The leading worldwide self-monitoring blood glucose market players are Roche Diagnostic, Abbott Laboratories, Dexcom, Inc., Medtronic, B. Braun Melsungen AG, and DarioHealth Corp. According to the data, these firms have a global market presence and hold a significant portion of the market. At the same time, the remaining manufacturers are limited to other local or regional manufacturers. Recent mergers and acquisitions between the participants have aided the corporations in strengthening their market presence.

Key topics covered:

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges

5. Global Blood Glucose (SMBG) Market and Users
5.1 Blood Glucose Device Market (Type1+Type2) Diabetes
5.1.1 Type 1 diabetes
5.1.2 Type 2 diabetes
5.2 Test Strips Market and Forecast
5.2.1 Type 1 diabetes
5.2.2 Type 2 diabetes
5.3 Lancet Market and Forecast
5.3.1 Type 1 diabetes
5.3.2 Type 2 diabetes
5.4 Meters Market and Forecast
5.4.1 Type 1 diabetes
5.4.2 Type 2 diabetes
5.5 Global Diabetes Population (Type 1 + Type 2)
5.5.1 Type 1 Diabetes Population
5.5.2 Type 2 Diabetes Population
5.6 Blood Glucose (SMBG) Device Users (Type1 + Type2)
5.6.1 Type 1 Diabetes Blood Glucose (SMBG) Device Users
5.6.2 Type 2 Diabetes Blood Glucose (SMBG) Device Users

6. Share Analysis – Blood Glucose Device Market, Diabetes Population, SMBG Users
6.1 SMBG Market Share
6.1.1 Total SMBG Market Share
6.1.1.1 Type 1
6.1.1.2 Type 2
6.1.2 Test strips
6.1.2.1 Type 1
6.1.2.2 Type 2
6.1.3 Lancet
6.1.3.1 Type 1
6.1.3.2 Type 2
6.1.4 Blood Glucose Meters
6.1.4.1 Type 1
6.1.4.2 Type 2
6.1.5 Diabetes Population Share
6.1.5.1 Type 1 diabetes
6.1.5.2 Type 2 diabetes
6.1.6.1 Type 1 diabetes
6.1.6.2 Type 2 diabetes

7. United States

8th. United Kingdom

9. Germany

10 Spain

11. Italy

12. Netherlands

13. Norway

14 Sweden

15 Switzerland

16 Australia

17 Kuwait

18 Brazil

19 Russia

20 India

21 China

22 South Africa

23 Saudi Arabia

24. Company Analysis
24.1 Roche Diagnostics
24.1.1 Overview
24.1.2 Recent Developments
24.1.3 Revenue
24.2 Abbott Laboratories
24.2.1 Overview
24.2.2 Recent Developments
24.2.3 Revenue
24.3 Dexcom, Inc.
24.3.1 Overview
24.3.2 Recent Developments
24.3.3 Revenue
24.4 Medtronic
24.4.1 Overview
24.4.2 Recent Developments
24.4.3 Revenue
24.5B. Braun Melsungen AG
24.5.1 Overview
24.5.2 Recent Developments
24.5.3 Revenue
24.6 Dario Health Corp
24.6.1 Overview
24.6.2 Recent Developments
24.6.3 Revenue

For more information about this report visit https://www.researchandmarkets.com/r/glomjp

Media contact:

Research and Markets
Laura WoodSenior Manager
press@researchandmarkets.com

For EST Office Hours Call +1-917-300-0470
For US/CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside US): +353-1-481-1716

surgery

surgery

View original content:https://www.prnewswire.com/news-releases/global-blood-glucose-device-market-report-2022-to-2027—key-drivers-and-challenges-301546904.html

SOURCE Research and Markets

Leave a Comment

Your email address will not be published.